Eli Lilly, Drug Maker of Zepbound and Mounjaro, Reaches $1 Trillion in Value

The New York Times – Business:

The 150-year-old drugmaker is the first company in health care to hit the milestone.

This post first appeared in The New York Times – Business. Read the original article.